Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Boeri

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Scientific Reports|July 29, 2017
Establishment of patient derived xenografts as functional testing of lung cancer aggressivenessMassimo Moro, Giulia Bertolini, Roberto Caserini, et al.
Scientific Reports|March 1, 2018
Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressivenessMassimo Moro, Giulia Bertolini, Roberto Caserini, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT PathwayMassimo Moro, Orazio Fortunato, Giulia Bertolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial studyGabriella Sozzi, Mattia Boeri, Marta Rossi, et al.
The Lancet Regional Health. Europe|September 25, 2024
Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trialMattia Boeri, Federica Sabia, Roberta E Ledda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2018
Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesLuis M Seijo, Nir Peled, Daniel Ajona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective StudyMattia Boeri, Massimo Milione, Claudia Proto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2016
Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening ParticipantsUgo Pastorino, Roberto Boffi, Alfonso Marchianò, et al.
Tumori|November 12, 2020
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in ItalyGiovanni Apolone, Emanuele Montomoli, Alessandro Manenti, et al.
Cancers|July 11, 2020
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture AnalysisMassimo Milione, Mattia Boeri, Anna Cantarutti, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Scientific Reports|July 29, 2017
Establishment of patient derived xenografts as functional testing of lung cancer aggressivenessMassimo Moro, Giulia Bertolini, Roberto Caserini, et al.
Scientific Reports|March 1, 2018
Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressivenessMassimo Moro, Giulia Bertolini, Roberto Caserini, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT PathwayMassimo Moro, Orazio Fortunato, Giulia Bertolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial studyGabriella Sozzi, Mattia Boeri, Marta Rossi, et al.
The Lancet Regional Health. Europe|September 25, 2024
Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trialMattia Boeri, Federica Sabia, Roberta E Ledda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2018
Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesLuis M Seijo, Nir Peled, Daniel Ajona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective StudyMattia Boeri, Massimo Milione, Claudia Proto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2016
Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening ParticipantsUgo Pastorino, Roberto Boffi, Alfonso Marchianò, et al.
Tumori|November 12, 2020
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in ItalyGiovanni Apolone, Emanuele Montomoli, Alessandro Manenti, et al.
Cancers|July 11, 2020
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture AnalysisMassimo Milione, Mattia Boeri, Anna Cantarutti, et al.
Pageof 6